| Dr Kristin A Colonna, OD | |
|
2335 172nd St Ne, Marysville, WA 98271-4753 | |
| (360) 651-1550 | |
| Not Available |
| Full Name | Dr Kristin A Colonna |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 16 Years |
| Location | 2335 172nd St Ne, Marysville, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053544668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 046.010190 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kaiser Foundation Health Plan Of Washington | 9032022579 | 1480 |
News Archive
Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx", as a therapy for blood cancers such as leukemia and lymphoma. The article, carlecortemcel-l, an ex vivo expanded umbilical cord blood cell graft for allogeneic transplantation, written by Dr. Ka Wah Chan and Dr. Demetrios Petropoulos, will be published in the November 2009 issue of Expert Opinion on Biological Therapy.
The Associated Press/NPR reports: "The Montana Supreme Court said Thursday that nothing in state law prevents patients from seeking physician-assisted suicide, making Montana the third state that will allow the procedure. Patients and doctors had been waiting for the state's high court to step in after a lower court decided a year ago that constitutional rights to privacy and dignity protect the right to die. The Montana Supreme Court opinion will now give doctors in the state the freedom to prescribe the necessary drugs to mentally competent, terminally ill patients without fear of being prosecuted, advocates said" (1/2).
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
A new nano-fabricated platform for observing brain cancer cells provides a much more detailed look at how the cells migrate and a more accurate post-surgery prognosis for brain cancer (glioblastoma) patients.
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
› Verified 1 days ago
| Provider Name | Kaiser Foundation Health Plan Of Washington |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396810701 PECOS PAC ID: 9032022579 Enrollment ID: O20031112000454 |
News Archive
Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx", as a therapy for blood cancers such as leukemia and lymphoma. The article, carlecortemcel-l, an ex vivo expanded umbilical cord blood cell graft for allogeneic transplantation, written by Dr. Ka Wah Chan and Dr. Demetrios Petropoulos, will be published in the November 2009 issue of Expert Opinion on Biological Therapy.
The Associated Press/NPR reports: "The Montana Supreme Court said Thursday that nothing in state law prevents patients from seeking physician-assisted suicide, making Montana the third state that will allow the procedure. Patients and doctors had been waiting for the state's high court to step in after a lower court decided a year ago that constitutional rights to privacy and dignity protect the right to die. The Montana Supreme Court opinion will now give doctors in the state the freedom to prescribe the necessary drugs to mentally competent, terminally ill patients without fear of being prosecuted, advocates said" (1/2).
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
A new nano-fabricated platform for observing brain cancer cells provides a much more detailed look at how the cells migrate and a more accurate post-surgery prognosis for brain cancer (glioblastoma) patients.
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristin A Colonna, OD 2335 172nd St Ne, Marysville, WA 98271-4753 Ph: (360) 651-1550 | Dr Kristin A Colonna, OD 2335 172nd St Ne, Marysville, WA 98271-4753 Ph: (360) 651-1550 |
News Archive
Gamida Cell announced today the publication of an article evaluating carlecortemcel-l, the generic name of what is widely known as "StemEx", as a therapy for blood cancers such as leukemia and lymphoma. The article, carlecortemcel-l, an ex vivo expanded umbilical cord blood cell graft for allogeneic transplantation, written by Dr. Ka Wah Chan and Dr. Demetrios Petropoulos, will be published in the November 2009 issue of Expert Opinion on Biological Therapy.
The Associated Press/NPR reports: "The Montana Supreme Court said Thursday that nothing in state law prevents patients from seeking physician-assisted suicide, making Montana the third state that will allow the procedure. Patients and doctors had been waiting for the state's high court to step in after a lower court decided a year ago that constitutional rights to privacy and dignity protect the right to die. The Montana Supreme Court opinion will now give doctors in the state the freedom to prescribe the necessary drugs to mentally competent, terminally ill patients without fear of being prosecuted, advocates said" (1/2).
This week PLoS Medicine publishes the third in a four-part series of policy papers examining the ways in which global health institutions and arrangements are changing and evolving.
A new nano-fabricated platform for observing brain cancer cells provides a much more detailed look at how the cells migrate and a more accurate post-surgery prognosis for brain cancer (glioblastoma) patients.
The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
› Verified 1 days ago
Dr. Jennifer Marie Christman, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 | |
Cody Good, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 | |
Marysville Vision Source Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1098 Alder Ave, Marysville, WA 98270 Phone: 360-659-6255 Fax: 360-653-2466 | |
Dr. Emily Camchau Do Nguyen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 16616 Twin Lakes, Marysville, WA 98271 Phone: 360-652-4543 Fax: 360-652-4544 | |
Daniel Samaniego, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1262 State Ave, Marysville, WA 98270 Phone: 360-651-7450 | |
Eye Doctors Ltd Ps Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1083 Cedar Ave, Marysville, WA 98270 Phone: 360-659-1446 Fax: 360-659-7324 |